Close Menu

sequence capture

Berlin-based Atlas Biolabs recently became certified under Roche NimbleGen's service provider program. It will offer DNA capture services using NimbleGen arrays followed by sequencing on 454's GS FLX.

The core facility, which is scheduled to receive the instrument later this month, plans to use Febit's HybSelect technology in conjunction with its Applied Biosystems SOLiD platform.

The German company will offer the sequence capture technology with next-generation sequencing services.

The company will provide sequence capture services using NimbleGen's technology.

As part of the deal, Heidelberg, Germany-based Febit will install several of Life Tech's SOLiDs and real-time PCR systems in its genomic-services facility, and aims to process around 1,000 samples per week by the first half of next year.

The alliance combines Febit's HybSelect sequence capture technology with Life Tech's SOLiD sequencing system.

The agreement, under which Life Technologies will co-market Agilent's SureSelect Target Enrichment System with the Applied Biosystems SOLiD sequencer, follows a similar deal that Agilent signed with Illumina in April.

By entering the target enrichment market, the Olink Bioscience subsidiary will compete with Agilent Technologies, Febit, Fluidigm, LC Sciences, RainDance Technologies, and Roche NimbleGen.

Scientists from the University of Washington and Agilent Technologies have sequenced the exomes of a dozen individuals, identifying a range of genetic variants that include disease-related mutations.

SeqWright CEO Fei Lu said this week that Lilly is one of an increasing number of pharma customers that have specifically requested sequence capture and sequencing services from the firm.


A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.